Sentence examples for unsatisfactory response to from inspiring English sources

An emerging entity is the non-responsive CD, which includes patients with an unsatisfactory response to GFD [ 46].

Japan's unsatisfactory response to the Allies' Potsdam Declaration decided the matter.

"Earnest" is the best Logan can do for Lehman's efforts on "The Oxford Book of American Poetry," and that's an unsatisfactory response to a guy of Lehman's poetic and editorial talents.

The Republican chairman of the House Intelligence Committee said Tuesday that prewar American intelligence about Iraq had been hampered by significant shortcomings, including what he called the C.I.A.'s unsatisfactory response to Congressional directives to improve its foreign language capacity.

Zeh also highlighted Merkel's unsatisfactory response to the issue and since then the chancellor has simply continued with hinhaltetaktik (delaying tactics), even peddling a weak argument that many emails sent within Germany go via a server in the US and may therefore be outside the jurisdiction of German law.

In the case of an unsatisfactory response to a triptan or headache recurrence, a NSAID can be used [38].

The policy has since been the subject of debate, with a report released in June by the French prisons auditor critical of what it called "disparate" and tentative measures hastily put in place, which offered "unsatisfactory" responses to the unprecedented phenomenon of radicalisation in French prisons.

We recruited consecutive CM patients, who had had an unsatisfactory responses to at least 3 pharmacological preventive therapies, including OnabotulinumtoxinA.

Dame Anne said basic failures - such as appointments being cancelled without notice or unsatisfactory responses to queries about claims - were happening too regularly and claimants had often been unable to get any information about when a decision would finally be made.

Two hundred fifty-five patients showing an unsatisfactory response or intolerance to at least one conventional disease-modifying antirheumatic drug (cDMARD) (methotrexate, leflunomide, sulfasalazine, or hydroxychloroquine) or at least one biologic DMARD (bDMARD) (infliximab, adalimumab, certolizumab, golimumab, abatacept, or tocilizumab) were included.

Briefly, eligible patients were ≥18 years of age, had adult-onset RA for ≥3 months as defined by the 1987 American College of Rheumatology (ACR) criteria, and showed an unsatisfactory response or intolerance to ≥1 csDMARD [ 8].